Product Information
CARBAMAZEPINE 200 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $0.1186 per EA under NDC 69452031220. Its NADAC has been published 98 times since Aug 14, 2024.
Strength
200 mg/1
Manufacturer
Bionpharma Inc.NDC
69452031220
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA218221On Market Since
3/15/2024
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE 200 MG TABLET has been published 98 times since Aug 14, 2024, and over the history we have for it it has risen 18.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1186 per EA |
|---|---|
| All-time high | $0.1977 (Dec 11, 2024) |
| All-time low | $0.1005 (Aug 14, 2024) |
| 52-week high | $0.1285 |
| 52-week low | $0.1157 |
| Median price | $0.1244 |
| Average price | $0.1358 |
| Largest weekly change | +96.7% (Aug 28, 2024) |
| Weeks tracked | 98 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 200 MG TABLET, manufactured by Bionpharma Inc., is $0.1186 per EA (NDC 69452031220), effective Jun 24, 2026.
How has the price of CARBAMAZEPINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE 200 MG TABLET has risen 18.1%. It has been tracked across 98 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 200 MG TABLET?
Since Aug 14, 2024, the NADAC for CARBAMAZEPINE 200 MG TABLET has ranged from a low of $0.1005 (Aug 14, 2024) to a high of $0.1977 (Dec 11, 2024), with a median of $0.1244 per EA.
Are there cheaper alternatives to CARBAMAZEPINE 200 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CARBAMAZEPINE 200 MG TABLET, but none are currently priced below it.
Who manufactures CARBAMAZEPINE 200 MG TABLET?
CARBAMAZEPINE 200 MG TABLET (NDC 69452031220) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification